Engineered bacteria can deliver antiviral therapies, vaccines
New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a delivery system for antiviral therapies and vaccines. The research, led by Nalinikanth Kotagiri, PhD, was recently published in the journal Gut Microbes. Study background Kotagiri’s lab focuses on engineering probiotic bacteria to accomplish a wide variety of […]
